90 related articles for article (PubMed ID: 8475616)
21. Bone scintigraphy in lung cancer: a reappraisal.
Merrick MV; Merrick JM
Br J Radiol; 1986 Dec; 59(708):1185-94. PubMed ID: 3801798
[TBL] [Abstract][Full Text] [Related]
22. Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features.
Salonia A; Gallina A; Camerota TC; Picchio M; Freschi M; DaPozzo LF; Guazzoni G; Fazio F; Rigatti P; Montorsi F
Urology; 2006 Aug; 68(2):362-6. PubMed ID: 16904453
[TBL] [Abstract][Full Text] [Related]
23. A reappraisal of serial isotope bone scans in prostate cancer.
O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF
Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
[TBL] [Abstract][Full Text] [Related]
24. [Value of 3-phase skeletal scintigraphy in the diagnosis of bone metastases].
Rieden K; Adolph J; Georgi P; zum Winkel K
Rofo; 1987 Aug; 147(2):138-42. PubMed ID: 2819965
[TBL] [Abstract][Full Text] [Related]
25. Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
Shih WJ; Wierzbinski B; Collins J; Magoun S; Chen IW; Ryo UY
J Nucl Med; 1990 Sep; 31(9):1486-9. PubMed ID: 1697617
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
27. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
Hotze A; Löw A; Mahlstedt J; Wolf F
Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
[TBL] [Abstract][Full Text] [Related]
28. Can serum prostate-specific antigen replace bone scintigraphy in the follow-up of metastatic prostatic cancer?
Sissons GR; Clements R; Peeling WB; Penney MD
Br J Radiol; 1992 Oct; 65(778):861-4. PubMed ID: 1384917
[TBL] [Abstract][Full Text] [Related]
29. Correlation of serum prostate specific antigen levels and bone scintigraphy in carcinoma prostate.
Oommen R; Geethanjali FS; Gopalakrishnan G; Chacko N; John S; Kanagasabapathy AS; Roul RK
Br J Radiol; 1994 May; 67(797):469-71. PubMed ID: 7514940
[TBL] [Abstract][Full Text] [Related]
30. Use of bone scintigraphy to select patients with multiple myeloma for treatment with strontium-89.
Edwards GK; Santoro J; Taylor A
J Nucl Med; 1994 Dec; 35(12):1992-3. PubMed ID: 7989983
[TBL] [Abstract][Full Text] [Related]
31. Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease.
Landgren O; Axdorph U; Jacobsson H; Johansson B; Grimfors G; Björkholm M
Med Oncol; 2000 Aug; 17(3):174-8. PubMed ID: 10962526
[TBL] [Abstract][Full Text] [Related]
32. Bone scintigraphy in staging of bladder carcinoma.
Brismar J; Gustafson T
Acta Radiol; 1988; 29(2):251-2. PubMed ID: 2965914
[TBL] [Abstract][Full Text] [Related]
33. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
[TBL] [Abstract][Full Text] [Related]
34. Skeletal metastases from hepatoma: frequency, distribution, and radiographic features.
Kuhlman JE; Fishman EK; Leichner PK; Magid D; Order SE; Siegelman SS
Radiology; 1986 Jul; 160(1):175-8. PubMed ID: 3012630
[TBL] [Abstract][Full Text] [Related]
35. Role of 99mTc methylene diphosphonate bone imaging in the management of lymphoma.
Anderson KC; Kaplan WD; Leonard RC; Skarin AT; Canellos GP
Cancer Treat Rep; 1985 Dec; 69(12):1347-51. PubMed ID: 4075310
[TBL] [Abstract][Full Text] [Related]
36. [Importance of whole body skeletal scintigraphy within the scope of staging of neoplasms in the ENT area].
Piepenburg R; Bockisch A; Hach A; Steinert H; Welkoborsky HJ; Kreuz S; Mann WJ; Hahn K
Laryngorhinootologie; 1992 Dec; 71(12):605-10. PubMed ID: 1492886
[TBL] [Abstract][Full Text] [Related]
37. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
[TBL] [Abstract][Full Text] [Related]
38. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
[TBL] [Abstract][Full Text] [Related]
39. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
40. Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review.
Fon GT; Wong WS; Gold RH; Kaiser LR
AJR Am J Roentgenol; 1981 Jul; 137(1):103-8. PubMed ID: 6787858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
